Sana Biotechnology SANA
$1.59 −$0.15 (-8.62%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $1.64 +3.06%
Open$1.70
Prev close$1.74
Day range$1.57 – $1.75
Volume4.46M
Market cap$476.42M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit$18.51M+142.5% YoY
Net profit$20.40M+148.4% YoY
Diluted EPS$0.07+143.8% YoY
Free cash flow-$39.54M-34.2% YoY
Operating cash flow-$38.75M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-79.5%
Return on assets-36.8%
Return on invested capital-60.1%
Current ratio1.77
Liabilities / assets52.0%
Cash & investments$121.73M
Total debt$40.52M
Net cash (debt)$81.20M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | -$18.51M | $65.42M | $48.61M | $205.71M | $61.20M |
| Selling and Admin Expenses | $10.94M | $10.78M | $11.46M | $44.30M | $12.19M |
| -General & Admin Expense | $10.94M | $10.78M | $11.46M | $44.30M | $12.19M |
| Research & Development | -$29.45M | $54.64M | $37.15M | $161.41M | $49.01M |
| Operating Profit | $18.51M | -$65.42M | -$48.61M | -$205.71M | -$61.20M |
| Net Non-Operating Interest Income (Expense) | $1.22M | $1.13M | $951,000.00 | $3.85M | $1.28M |
| Non-Operating Interest Income | $1.22M | $1.13M | $951,000.00 | $3.85M | $1.28M |
| Other Income (Expense) | $676,000.00 | $656,000.00 | $453,000.00 | -$42.31M | $1.10M |
| Special Income (Charges) | $0.00 | $0.00 | – | -$44.61M | $0.00 |
| -Less:Impairment of Capital Assets | $0.00 | $0.00 | – | $44.61M | $0.00 |
| Other Non-Operating Income (Expenses) | $676,000.00 | $656,000.00 | $453,000.00 | $2.31M | $1.10M |
| Pretax Profit | $20.40M | -$63.64M | -$47.21M | -$244.17M | -$58.83M |
| Net Profit | $20.40M | -$63.64M | -$47.21M | -$244.17M | -$58.83M |
| Profit from Continuing Operations | $20.40M | -$63.64M | -$47.21M | -$244.17M | -$58.83M |
| Net Income to Parent Company | $20.40M | -$63.64M | -$47.21M | -$244.17M | -$58.83M |
| Net Income to Common Stockholders | $20.40M | -$63.64M | -$47.21M | -$244.17M | -$58.83M |
| Basic EPS | $0.07 | -$0.22 | -$0.17 | -$0.96 | -$0.21 |
| Diluted EPS | $0.07 | -$0.22 | -$0.17 | -$0.96 | -$0.21 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $376.13M | $431.52M | $373.59M | $416.89M | $416.89M |
| Total Current Assets | $132.31M | $170.63M | $111.69M | $148.68M | $148.68M |
| Cash and Cash Equivalents & Short-Term Investments | $121.73M | $160.49M | $101.14M | $138.38M | $138.38M |
| -Cash and Cash Equivalents | $41.10M | $57.07M | $83.80M | $71.87M | $71.87M |
| -Short Term Investments | $80.62M | $103.42M | $17.34M | $66.51M | $66.51M |
| Restricted Cash | $3.76M | $4.20M | $4.20M | $4.20M | $4.20M |
| Other Current Assets | $6.82M | $5.94M | $6.36M | $6.10M | $6.10M |
| Total Non-Current Assets | $243.82M | $260.89M | $261.90M | $268.21M | $268.21M |
| Net PPE | $43.44M | $60.52M | $61.52M | $65.22M | $65.22M |
| -Gross PPE | $105.47M | $119.90M | $118.66M | $119.97M | $119.97M |
| -Accumulated Depreciation | -$62.03M | -$59.38M | -$57.15M | -$54.76M | -$54.76M |
| Goodwill and Other Intangible Assets | $199.82M | $199.82M | $199.82M | $199.82M | $199.82M |
| -Goodwill | $140.63M | $140.63M | $140.63M | $140.63M | $140.63M |
| -Other Intangible Assets | $59.20M | $59.20M | $59.20M | $59.20M | $59.20M |
| Other Non-Current Assets | $551,000.00 | $552,000.00 | $563,000.00 | $3.17M | $3.17M |
| Total Liabilities | $195.76M | $276.95M | $254.35M | $256.01M | $256.01M |
| Total Current Liabilities | $74.88M | $123.75M | $86.27M | $78.73M | $78.73M |
| Payables | $1.95M | $1.36M | $2.12M | $1.67M | $1.67M |
| -Accounts Payable | $1.95M | $1.36M | $2.12M | $1.67M | $1.67M |
| Current Accrued Expenses | $9.70M | $9.67M | $10.32M | $10.19M | $10.19M |
| Short-Term Debt and Capital Lease Obligation | $13.32M | $14.51M | $14.88M | $14.94M | $14.94M |
| -Current Capital Lease Obligation | $13.32M | $14.51M | $14.88M | $14.94M | $14.94M |
| Other Current Liabilities | $40.65M | $90.81M | $53.56M | $40.20M | $40.20M |
| Total Non-Current Liabilities | $120.88M | $153.20M | $168.09M | $177.28M | $177.28M |
| Long Term Debt and Capital Lease Obligation | $40.52M | $59.23M | $60.45M | $63.92M | $63.92M |
| -Long Term Capital Lease Obligation | $40.52M | $59.23M | $60.45M | $63.92M | $63.92M |
| Other Non-Current Liabilities | $80.36M | $93.97M | $107.64M | $113.36M | $113.36M |
| Total Equity | $180.36M | $154.57M | $119.24M | $160.88M | $160.88M |
| Stockholders' Equity | $180.36M | $154.57M | $119.24M | $160.88M | $160.88M |
| Capital Stock | $30,000.00 | $30,000.00 | $27,000.00 | $27,000.00 | $27,000.00 |
| -Common Stock | $30,000.00 | $30,000.00 | $27,000.00 | $27,000.00 | $27,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $2.12B | $2.11B | $2.02B | $2.01B | $2.01B |
| Retained Earnings | -$1.94B | -$1.96B | -$1.90B | -$1.85B | -$1.85B |
| Gains/Losses Not Affecting Retained Earnings | -$104,000.00 | -$66,000.00 | -$2,000.00 | $28,000.00 | $28,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$38.75M | -$32.79M | -$37.38M | -$143.83M | -$32.64M |
| Net cash flow from continuing operations | -$38.75M | -$32.79M | -$37.38M | -$143.83M | -$32.64M |
| Net Income from Continuing Operations | $20.40M | -$63.64M | -$47.21M | -$244.17M | -$58.83M |
| Depreciation & Depletion & Amortization | $2.97M | $2.23M | $2.39M | $12.75M | $3.05M |
| Other Non-Cash Items | -$61.19M | $22.15M | $8.29M | $27.63M | $13.38M |
| Change in Working Capital | -$6.26M | $1.12M | -$6.51M | -$10.11M | $3.41M |
| -Change in Prepaid Assets | -$805,000.00 | $295,000.00 | $1.63M | $1.17M | -$696,000.00 |
| -Change in Payables and Accrued Expense | $1.94M | $271,000.00 | -$6.64M | -$8.28M | $5.57M |
| -Change In Other Working Capital | -$7.40M | $556,000.00 | -$1.50M | -$3.00M | -$1.46M |
| Net cash flow from investing | $22.35M | -$87.52M | $49.44M | -$40.24M | -$16.50M |
| Net Cash Flow from Continuing Investing Activities | $22.35M | -$87.52M | $49.44M | -$40.24M | -$16.50M |
| Net PPE Purchase and Sale | -$791,000.00 | -$1.62M | -$288,000.00 | -$938,000.00 | -$873,000.00 |
| Net Investment Purchase and Sale | $23.10M | -$85.92M | $49.48M | -$40.73M | -$16.28M |
| Net Other Investing Changes | $45,000.00 | $23,000.00 | $248,000.00 | $1.43M | $661,000.00 |
| Financing Cash Flow | $0.00 | $93.58M | -$128,000.00 | $128.73M | $17.65M |
| Net Cash Flow from Continuing Financing Activities | $0.00 | $93.58M | -$128,000.00 | $128.73M | $17.65M |
| Net Common Stock Issuance | -$24,000.00 | – | – | – | – |
| Proceeds from Stock Option Exercised | $117,000.00 | $245,000.00 | $59,000.00 | $2.68M | $1.06M |
| Net Other Financing Charges | -$93,000.00 | -$88,000.00 | -$96,000.00 | – | – |
| Ending Cash Balance | $44.87M | $61.27M | $88.00M | $76.07M | $76.07M |
| Net Change in Cash | -$16.40M | -$26.73M | $11.93M | -$55.33M | -$31.49M |
| Beginning Cash Balance | $61.27M | $88.00M | $76.07M | $131.40M | $107.55M |
| Free Cash Flow | -$39.54M | -$34.41M | -$37.67M | -$144.77M | -$33.51M |
| Net Issuance Payments Of Debt | – | – | -$91,000.00 | $126.06M | – |
No comments yet — be the first to weigh in on SANA.
Sign in to join the discussion.